50 related articles for article (PubMed ID: 15890581)
1. Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy.
Feigenberg SJ; Hanlon AL; Horwitz EM; Uzzo RG; Eisenberg D; Pollack A
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):397-405. PubMed ID: 15890581
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.
Lawton CA; Bae K; Pilepich M; Hanks G; Shipley W
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):437-41. PubMed ID: 17881145
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial.
Mariados NF; Orio PF; Schiffman Z; Van TJ; Engelman A; Nurani R; Kurtzman SM; Lopez E; Chao M; Boike TP; Martinez AA; Gejerman G; Lederer J; Sylvester JE; Bell G; Rivera D; Shore N; Miller K; Sinayuk B; Steinberg ML; Low DA; Kishan AU; King MT
JAMA Oncol; 2023 Apr; 9(4):511-518. PubMed ID: 36757690
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for rectal bleeding after volumetric-modulated arc radiotherapy of prostate cancer.
Otsuka K; Otsuka M; Itaya T; Matsumoto A; Sato R; Sagara Y; Oga M; Asayama Y
Rep Pract Oncol Radiother; 2023; 28(1):15-23. PubMed ID: 37122916
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate and high risk prostate cancer.
Soni A; Jadhav GK; Manocha S; Chauhan S; Goswami B; Verma M
Rep Pract Oncol Radiother; 2022; 27(6):1001-1009. PubMed ID: 36632300
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Late Toxicity After Whole-pelvis
Ogino R; Ishii K; Nakajima T; Hosokawa Y; Kubo K; Takemura R; Morimoto H; Matsuda S; Kawamorita R; Tada T
Cancer Diagn Progn; 2022; 2(6):648-653. PubMed ID: 36340451
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.
van Dams R; Jiang NY; Fuller DB; Loblaw A; Jiang T; Katz AJ; Collins SP; Aghdam N; Suy S; Stephans KL; Yuan Y; Nickols NG; Murthy V; Telkhade TP; Kupelian PA; Steinberg ML; Romero T; Kishan AU
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):731-737. PubMed ID: 33493615
[TBL] [Abstract][Full Text] [Related]
8. Long term results of the NRG/RTOG 9413: a key study but one of the most confusing study in prostate cancer radiotherapy!
Pommier P
Transl Androl Urol; 2019 Jul; 8(Suppl 3):S257-S260. PubMed ID: 31392138
[No Abstract] [Full Text] [Related]
9. Association between rectal bleeding and the absolute dose volume of the rectum following image-guided radiotherapy for patients with prostate cancer.
Kotabe K; Nakayama H; Takashi A; Takahashi A; Tajima T; Kume H
Oncol Lett; 2018 Aug; 16(2):2741-2749. PubMed ID: 30013669
[TBL] [Abstract][Full Text] [Related]
10. Early Experiences of Image Guided Prostate and Pelvic Nodal Irradiation With Intensity Modulated Radiation Treatment in Localized Prostate Cancer.
Ko C; Ning H; Lita E; McNally D; Wood BJ; Choyke P; Guion P; Smith S; Krieger A; Camphausen K; Singh AK; Kaushal A
World J Oncol; 2012 Feb; 3(1):16-22. PubMed ID: 29147273
[TBL] [Abstract][Full Text] [Related]
11. Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia.
Gonzalez BD; Small BJ; Cases MG; Williams NL; Fishman MN; Jacobsen PB; Jim HSL
Cancer; 2018 Feb; 124(3):499-506. PubMed ID: 29072790
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dosimetric parameters and acute toxicity after whole-pelvic vs prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer.
Ishii K; Ogino R; Hosokawa Y; Fujioka C; Okada W; Nakahara R; Kawamorita R; Tada T; Hayashi Y; Nakajima T
Br J Radiol; 2016 Jun; 89(1062):20150930. PubMed ID: 26959612
[TBL] [Abstract][Full Text] [Related]
13. International prostate symptom score (IPSS) change and changing factor in intensity-modulated radiotherapy combined with androgen deprivation therapy for prostate cancer.
Tomita N; Oze I; Shimizu H; Yoshida M; Kimura K; Takehana K; Shimizu A; Makita C; Tachibana H; Kodaira T; Soga N; Ogura Y; Hayashi N
Nagoya J Med Sci; 2015 Nov; 77(4):637-46. PubMed ID: 26663942
[TBL] [Abstract][Full Text] [Related]
14. Impact of the duration of hormonal therapy following radiotherapy for localized prostate cancer.
Okubo M; Nakayama H; Itonaga T; Tajima YU; Shiraishi S; Mikami R; Sakurada A; Sugahara S; Koizumi K; Tokuuye K
Oncol Lett; 2015 Jul; 10(1):255-259. PubMed ID: 26171009
[TBL] [Abstract][Full Text] [Related]
15. Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysis.
Yamazaki H; Nakamura S; Nishimura T; Yoshida K; Yoshioka Y; Koizumi M; Ogawa K
J Radiat Res; 2014 Nov; 55(6):1033-47. PubMed ID: 25204643
[TBL] [Abstract][Full Text] [Related]
16. Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial.
Mantini G; Fersino S; Alitto AR; Frascino V; Massaccesi M; Fionda B; Iorio V; Luzi S; Balducci M; Mattiucci GC; Di Nardo F; De Belvis A; Morganti AG; Valentini V
Biomed Res Int; 2014; 2014():480725. PubMed ID: 25093169
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer.
Harada K; Ishikawa H; Saito Y; Nakamoto S; Kawamura H; Wakatsuki M; Etsunaga T; Takezawa Y; Kobayashi M; Nakano T
J Radiat Res; 2012 Nov; 53(6):923-9. PubMed ID: 22859567
[TBL] [Abstract][Full Text] [Related]
18. Concurrent androgen deprivation therapy during salvage prostate radiotherapy improves treatment outcomes in high-risk patients.
Soto DE; Passarelli MN; Daignault S; Sandler HM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1227-32. PubMed ID: 21549519
[TBL] [Abstract][Full Text] [Related]
19. Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer.
Guckenberger M; Ok S; Polat B; Sweeney RA; Flentje M
Strahlenther Onkol; 2010 Oct; 186(10):535-43. PubMed ID: 20890743
[TBL] [Abstract][Full Text] [Related]
20. Intensity Modulated Radiation Therapy Reduces Gastrointestinal Toxicity in Patients Treated with Androgen Deprivation Therapy for Prostate Cancer.
Sharma NK; Li T; Chen DY; Pollack A; Horwitz EM; Buyyounouski MK
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):S10. PubMed ID: 20664712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
